NM_021098.3:c.15A>C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_021098.3(CACNA1H):c.15A>C(p.Ala5Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000189 in 1,060,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000019 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.02
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 16-1153752-A-C is Benign according to our data. Variant chr16-1153752-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 1555761.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.02 with no splicing effect.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.15A>C | p.Ala5Ala | synonymous_variant | Exon 2 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.15A>C | non_coding_transcript_exon_variant | Exon 2 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome AF: 0.00000189 AC: 2AN: 1060966Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 501962 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
2
AN:
1060966
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
501962
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
21676
American (AMR)
AF:
AC:
0
AN:
7368
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
12886
East Asian (EAS)
AF:
AC:
0
AN:
23472
South Asian (SAS)
AF:
AC:
0
AN:
22506
European-Finnish (FIN)
AF:
AC:
0
AN:
20988
Middle Eastern (MID)
AF:
AC:
0
AN:
2764
European-Non Finnish (NFE)
AF:
AC:
2
AN:
907658
Other (OTH)
AF:
AC:
0
AN:
41648
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.029673), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jul 26, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.